Option chain shows key data for Coeptis Therapeutics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Coeptis Therapeutics.

Coeptis Therapeutics (NASDAQ:COEP) Stock, Option Chain

Coeptis Therapeutics

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

movers image

Movers

Trading Ideas

ARKR

AURA

BLRX

CHEK

CMCT

COEP

IDAI

LINC

MGOL

NINE

RSVR

Why Check-Cap Shares Are Trading Higher By Over 52%; Here Are 20 Stocks Moving Premarket

benzinga_deal_dispatch2

Asset Sales

Legal

AMPS

BABA

BIGGQ

CPNG

VIRX

Unlike Party City and Big Lots, The Container Store is staying in business. Plus, an oncology company searches for a deal.

Deal Dispatch: Party City Wraps Up, Big Lots Goes Bust, The Container Store Continues

Photo by solarseven on Shutterstock

Equities

News

Stock Split

Markets

General

Coeptis Therapeutics stock drops 22.5% after announcing a 1-for-20 reverse stock split to meet Nasdaq&#39;s listing requirements.





Why Is Coeptis Therapeutics Stock Falling On Friday?

Coeptis Therapeutics Holdings, Inc. - Common Stock

Coeptis Therapeutics Holdings Inc

Coeptis Therapeutics Holdings, Inc. - Warrants

Press Releases

Coeptis Therapeutics Regains Compliance with Nasdaq Listing Rule 5550(a)(2)

Small Cap

Coeptis Therapeutics Leverages Artificial Intelligence and Blockchain for Next-Generation Innovation

Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation

COEPTIS Completes $10 Million Series A Preferred Financing Round, Reinforcing Commitment to Technological Innovation and AI Integration

Biotech

COEPTIS Announces the Launch of COEP Venture Group to Invest in AI, RPA, and AI Agent Startups

COEPTIS NexGenAI Affiliates Network & MarketLeverage Announce Strategic Partnership to Revolutionize AI-Powered Affiliate Marketing

COEPTIS' NexGenAI Partners with Arketyp Valu to Revolutionize Digital Engagement on the Verus Network

NUBURU Partners With COEPTIS NexGenAI Affiliates Network to Drive Innovation in AI and Robotics as Part of Its Transformation Plan

COEPTIS' NexGenAI Affiliates Partners with NUBURU Network to Drive Innovation in AI and Robotics as Part of its Transformation Plan

Health Care

Coeptis Therapeutics Secures Worldwide Development and Commercialization Rights to Next-Generation GEAR™ Cell Therapy Platform Strengthening its High-Impact Precision Immuno-Oncology Pipeline

BURU

Annovis Bio

Actinium Pharmaceuticals, Inc. (Delaware) Common Stock

Actinium Pharma

Atara Biotherapeutics, Inc. - Common Stock

Atara Biotherapeutics

bluebird bio

CASI Pharmaceuticals, Inc. - Ordinary Shares

CASI Pharmaceuticals

Celularity

CollPlant Biotechnologies Ltd. - Ordinary Shares

CollPlant Biotechnologies

Clene

Precision BioSciences, Inc. - Common Stock

Precision BioSciences

Estrella Immunopharma, Inc. - Common Stock

Estrella Immunopharma

FibroBiologics

Forte Biosciences

Generation Bio

Intensity Therapeutics, Inc. - Common Stock

Intensity Therapeutics

LakeShore Biopharma Co., Ltd - Ordinary Shares

LakeShore Biopharma

OSR Holdings

OS Therapies

Ovid Therapeutics

Pluri

Prelude Therapeutics Incorporated - Common Stock

Prelude Therapeutics

RenovoRx

Surrozen

Tempest Therapeutics, Inc. - Common Stock

Tempest Therapeutics

vTv Therapeutics Inc. - Class A Common Stock

vTv Therapeutics

Exicure

Ladenburg Thalmann

EF Hutton

JonesTrading

Screenshot 2024-02-29 at 7.16.11 PM

ATNM

Here&#39;s How Coeptis Therapeutics Is Innovating Cell Therapy Approaches

Comments

Coeptis Therapeutics

Coeptis Therapeutics (COEP) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga